Deficiency of placental GDF15 causes fetal growth restriction by inhibiting fetal hepatic STAT3-IGF2 axis
PLOS Biology · 2026
DOI: 10.1371/journal.pbio.3004061 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2026. Verfasst von Xiao Peng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University,…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Liver, Fetal Growth Retardation, Insulin-Like Growth Factor II. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technologies Research and Development Program.
Abstract (Originalsprache)
Fetal growth restriction (FGR) is a major cause of perinatal morbidity and mortality, yet its underlying mechanism remains elusive. Here, we show that growth differentiation factor 15 (GDF15) levels are significantly reduced in the placenta and fetal circulation in mouse and pig FGR models and correlate positively with fetal weight. Placenta-specific GDF15 deficiency causes FGR, while placenta-specific Gdf15 mRNA delivery through targeted lipid nanoparticle (LNP) effectively alleviates FGR. Mechanistically, placental GDF15 is a major contributor to the fetal circulating GDF15 pool and enters the fetal compartment, where it activates the hepatic STAT3 signaling pathway to stimulate IGF2 production during pregnancy. Placental GDF15 deficiency decreases hepatic STAT3 phosphorylation and IGF2 levels in fetuses. Inhibition of STAT3 in primary mouse fetal hepatocytes blocks GDF15-induced IGF2 upregulation. Placenta-specific Gdf15 mRNA-LNP administration rescues the decreased hepatic p-STAT3 and IGF2 levels in FGR fetuses. Collectively, our findings identify a placenta-fetal liver metabolic axis where placental GDF15 promotes fetal growth by activating the fetal hepatic STAT3-IGF2 pathway, revealing a potential therapeutic target for FGR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
ORCID-Profile: Jiang Wei Wu
Förderung
- Key Technologies Research and Development Program
Zitieren
APA
Liu, X. P., Zhang, X., Cai, C. X., Qin, M. M., Leng, X. K., Chen, J. H., Han, Y. F., Xiao, J. Y., Huang, J. H., & Wu, J. W. (2026). Deficiency of placental GDF15 causes fetal growth restriction by inhibiting fetal hepatic STAT3-IGF2 axis. PLOS Biology. https://doi.org/10.1371/journal.pbio.3004061
Vancouver
Liu XP, Zhang X, Cai CX, Qin MM, Leng XK, Chen JH, et al. Deficiency of placental GDF15 causes fetal growth restriction by inhibiting fetal hepatic STAT3-IGF2 axis. PLOS Biology. 2026. doi:10.1371/journal.pbio.3004061
BibTeX
@article{Liu2026,
author = {Liu, Xiao Peng and Zhang, Xiao and Cai, Chun Xia and Qin, Miao Miao and Leng, Xiang Kai and Chen, Jia Hao and Han, Yi Fan and Xiao, Jun Ying and Huang, Jia He and Wu, Jiang Wei},
title = {Deficiency of placental GDF15 causes fetal growth restriction by inhibiting fetal hepatic STAT3-IGF2 axis},
journal = {PLOS Biology},
year = {2026},
doi = {10.1371/journal.pbio.3004061}
}
EUVIMED